Literature DB >> 3528264

Diagnosis and treatment of localized juvenile periodontitis.

J J Zambon, L A Christersson, R J Genco.   

Abstract

An actinomycetemcomitans can cause localized juvenile periodontitis and certain types of adult periodontitis. Optimal treatment of periodontal disease caused by this microorganism requires systemic antibiotic therapy in addition to mechanical debridement of the infected gingival tissues. Laboratory techniques are available to assist the practitioner in identifying this microorganism in dental plaque samples.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3528264     DOI： 10.14219/jada.archive.1986.0152

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN： 0002-8177            Impact factor:   3.634


  11 in total

1.  Evidence for invasion of a human oral cell line by Actinobacillus actinomycetemcomitans.

Authors:  D H Meyer; P K Sreenivasan; P M Fives-Taylor
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

2.  Role of CD14 molecules in internalization of Actinobacillus actinomycetemcomitans by macrophages and subsequent induction of apoptosis.

Authors:  M Muro; T Koseki; S Akifusa; S Kato; Y Kowashi; Y Ohsaki; K Yamato; M Nishijima; T Nishihara
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

3.  Actinobacillus actinomycetemcomitans Y4 capsular polysaccharide induces IL-1beta mRNA expression through the JNK pathway in differentiated THP-1 cells.

Authors:  T Iwata; A Mitani; Y Ishihara; S Tanaka; G Yamamoto; T Kikuchi; T Naganawa; Y Matsumura; T Suga; M Koide; T Sobue; T Suzuki; T Noguchi
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

4.  Bone resorption caused by three periodontal pathogens in vivo in mice is mediated in part by prostaglandin.

Authors:  Y Zubery; C R Dunstan; B M Story; L Kesavalu; J L Ebersole; S C Holt; B F Boyce
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

5.  Mouse interleukin-1 receptor antagonist induced by Actinobacillus actinomycetemcomitans lipopolysaccharide blocks the effects of interleukin-1 on bone resorption and osteoclast-like cell formation.

Authors:  T Nishihara; Y Ohsaki; N Ueda; N Saito; G R Mundy
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

6.  Membrane morphology and leukotoxin secretion are associated with a novel membrane protein of Aggregatibacter actinomycetemcomitans.

Authors:  Claude V Gallant; Maja Sedic; Erin A Chicoine; Teresa Ruiz; Keith P Mintz
Journal:  J Bacteriol       Date:  2008-07-11       Impact factor: 3.490

7.  Murine macrophage interleukin-1 release by capsularlike serotype-specific polysaccharide antigens of Actinobacillus actinomycetemcomitans.

Authors:  T Takahashi; T Nishihara; Y Ishihara; K Amano; N Shibuya; I Moro; T Koga
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

8.  Actinobacillus actinomycetemcomitans Y4 capsular-polysaccharide-like polysaccharide promotes osteoclast-like cell formation by interleukin-1 alpha production in mouse marrow cultures.

Authors:  T Nishihara; N Ueda; K Amano; Y Ishihara; H Hayakawa; T Kuroyanagi; Y Ohsaki; K Nagata; T Noguchi
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

9.  A consortium of Aggregatibacter actinomycetemcomitans, Streptococcus parasanguinis, and Filifactor alocis is present in sites prior to bone loss in a longitudinal study of localized aggressive periodontitis.

Authors:  Daniel H Fine; Kenneth Markowitz; Karen Fairlie; Debbie Tischio-Bereski; Javier Ferrendiz; David Furgang; Bruce J Paster; Floyd E Dewhirst
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

Review 10.  Amoxicillin/Metronidazole Dose Impact as an Adjunctive Therapy for Stage II - III Grade C Periodontitis (Aggressive Periodontitis) at 3- And 6-Month Follow-Ups: a Systematic Review and Meta-Analysis.

Authors:  Malihe Karrabi; Zahra Baghani
Journal:  J Oral Maxillofac Res       Date:  2022-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.